Peritoneal mesothelial cell-derived extracellular vesicles provide a new mechanism for platinumresistant ovarian cancer through the enrichment of miR-135a-5p, which activates JAK-STAT signaling and suggests JAK as a key therapeutic target. The gene discussed is SOAT1; the disease is ovarian cancer.